** = Publikationen gelistet in SCI/SSCI/Pubmed
** Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Maceski, AM; Benkert, P; Bachmaier, G; Ropele, S; Reindl, M; Leppert, D; Kuhle, J; Enzinger, C; Khalil, M
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Eur J Neurol. 2023; 30(5):1389-1399
Doi: 10.1111/ene.15742
Web of Science
PubMed
FullText
FullText_MUG
** Callegari, I; Oechtering, J; Schneider, M; Perriot, S; Mathias, A; Voortman, MM; Cagol, A; Lanner, U; Diebold, M; Holdermann, S; Kreiner, V; Becher, B; Granziera, C; Junker, A; Du, Pasquier, R; Khalil, M; Kuhle, J; Kappos, L; Sanderson, NSR; Derfuss, T
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
Brain. 2023;
Doi: 10.1093/brain/awad424
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Callegari, I; Schneider, M; Aebischer, V; Voortman, MM; Proschmann, U; Ziemssen, T; Lindberg, R; Fischer-Barnicol, B; Khalil, M; Kappos, L; Kuhle, J; Sanderson, NSR; Derfuss, T
Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.
Ther Adv Neurol Disord. 2023; 16: 17562864221150040
Doi: 10.1177/17562864221150040
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** International Multiple Sclerosis Genetics Consortium; MultipleMS Consortium
Locus for severity implicates CNS resilience in progression of multiple sclerosis.
Nature. 2023;
Doi: 10.1038/s41586-023-06250-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pieber, TR; Asong, M; Fluhr, G; Holler, V; Kristensen, NR; Larsen, JH; Ribel-Madsen, R; Svehlikova, E; Vinther, S; Voortman, M; Haahr, H
Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes
DIABETES OBES METAB. 2023;
Doi: 10.1111/dom.15266
Web of Science
PubMed
FullText
FullText_MUG
** Fissolo, N; Matute-Blanch, C; Osman, M; Costa, C; Pinteac, R; Miró, B; Sanchez, A; Brito, V; Dujmovic, I; Voortman, M; Khalil, M; Borràs, E; Sabidó, E; Issazadeh-Navikas, S; Montalban, X; Comabella Lopez, M
CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS.
Neurol Neuroimmunol Neuroinflamm. 2021; 8(2):
Doi: 10.1212/NXI.0000000000000941
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Voortman, MM; Damulina, A; Pirpamer, L; Pinter, D; Pichler, A; Enzinger, C; Ropele, S; Bachmaier, G; Archelos, JJ; Marsche, G; Khalil, M
Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis.
Biomolecules. 2021; 11(9):
Doi: 10.3390/biom11091264
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M
Serum Neurofilament Light Levels Correlate with Reduced Gray Matter Volume in Advanced Multiple Sclerosis
NEUROLOGY. 2021; 96(15):
[Poster]
Web of Science
FullText
** Bsteh, G; Berek, K; Hegen, H; Teuchner, B; Buchmann, A; Voortman, MM; Auer, M; Wurth, S; Zinganell, A; Di, Pauli, F; Deisenhammer, F; Khalil, M; Berger, T
Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis.
Mult Scler. 2020; 26(13):1682-1690
Doi: 10.1177/1352458519882279
Web of Science
PubMed
FullText
FullText_MUG
** Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Barro, C; Leppert, D; Benkert, P; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J
Serum neurofilament light levels in normal aging and their association with morphologic brain changes.
Nat Commun. 2020; 11(1):812-812
Doi: 10.1038/s41467-020-14612-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leurs, CE; Twaalfhoven, H; Lissenberg-Witte, BI; van, Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez-Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Walchhofer, LM; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Scarpini, E; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, P; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La, Puma, D; Vercammen, M; Vanopdenbosch, L; Uitdehaag, B; Killestein, J; Bridel, C; Teunissen, C
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Mult Scler. 2020; 26(8):912-923
Doi: 10.1177/1352458519845844
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M
Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):192-193.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK.
[Onlinepräsentation]
Web of Science
** Buchmann, A; Pirpamer, L; Voortman, M; Pinter, D; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M
#2630 Serum Neurofilament Light Correlates with Reduced Grey Matter Volume in Advanced Multiple Sclerosis.
European Journal of Neurology, May 2020. 2020; 27(Suppl1):45-45.-6th EAN Congress; MAY 23-25, 2020 ; Paris, FRANCE.
[Oral Communication]
Web of Science
FullText
** Bsteh, G; Berek, K; Hegen, H; Buchmann, A; Voortman, MM; Auer, M; Wurth, S; Zinganell, A; Di Pauli, F; Deisenhammer, F; Khalil, M; Berger, T
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2019; 5(4): 2055217319885987-2055217319885987.
Doi: 10.1177/2055217319885987
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fissolo, N; Cervera-Carles, L; Villar Guimerans, LM; Lleó, A; Clarimón, J; Drulovic, J; Dujmovic, I; Voortman, M; Khalil, M; Gil, E; Navarro, L; Álvarez-Cermeño, JC; Montalban, X; Comabella, M
Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
Mult Scler. 2019; 25(11):1535-1538
Doi: 10.1177/1352458518786055
Web of Science
PubMed
FullText
FullText_MUG
** Khalil, M; Pirpamer, L; Hofer, E; Voortman, M; Barro, C; Leppert, D; Benkert, P; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J
Serum neurofilament light levels in normal aging: associations with morphologic brain changes
EUR J NEUROL. 2019; 26: 17-18.
[Oral Communication]
Web of Science
** Stryeck, S; Voortman, M; Enzinger, C; Fuchs, S; Deisenhammer, F; Hegen, H; Fazekas, F; Madl, T; Khalil, M
Serum NMR spectroscopy metabolomic profiles indicate progressive multiple sclerosis
EUR J NEUROL. 2019; 26: 241-241.
[Poster]
Web of Science
** Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M
The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2018; 4(3):2055217318800810-2055217318800810
Doi: 10.1177/2055217318800810
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, HJ; Fazekas, F; Khalil, M
Immunomodulatory therapy reduces elevated nitric oxide levels in multiple sclerosis patients
EUR J NEUROL. 2018; 25: 254-254.-4th Congress of the European Academy of Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL.
[Poster]
Web of Science
** Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Hallwirth, F; Barro, C; Fazekas, F; Schmidt, R; Kuhle, J
Normative values of serum neurofilament light levels
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):657-658.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY.
[Poster]
Web of Science
FullText
** Voortman, M; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos-Garcia, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early Multiple Sclerosis (MS)
EUR J NEUROL. 2018; 25: 434-434.-4th Congress of the European-Academy-of-Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
** Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M
The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):255-255.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY.
[Poster]
Web of Science
FullText
** Gattringer, T; Pinter, D; Enzinger, C; Seifert-Held, T; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Gröbke, S; Voortman, M; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M
Serum neurofilament light is sensitive to active cerebral small vessel disease.
Neurology. 2017; 89(20):2108-2114
Doi: 10.1212/WNL.0000000000004645
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Voortman, MM; Pekar, T; Bachmayer, D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.
Mult Scler J Exp Transl Clin. 2017; 3(3):2055217317727294-2055217317727294
Doi: 10.1177/2055217317727294
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Mult Scler. 2017; 23(11):1496-1505
Doi: 10.1177/1352458516681503
[Oral Communication]
Web of Science
PubMed
FullText
FullText_MUG
** Fissolo, N; Issazadeh-Navikas, S; Dujmovic, I; Voortman, MM; Khalil, M; Montalban, X; Comabella, M.
Serpina3n: potential biomarker in patients with progressive multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):219-219.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
FullText
** Gattringer, T; Pinter, D; Enzinger, C; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Grobke, S; Voortman, M; Seifert-Held, T; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M
Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease.
EUR J NEUROL. 2017; 24: 462-462.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS.
[Oral Communication]
Web of Science
** Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M
Serum nitric oxide is increased in untreated multiple sclerosis patients.
Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
** Leurs CE; Twaalfhoven, HAM; Witte, BI; Van Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, PE; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La Puma, D; Vercammen, MJ; VanopdenBosch, L; Uitdehaag, BMJ; Killestein, J; Teunissen, C.
Kappa free light chains: an automated alternative to oligoclonal bands for CIS and MS diagnosis?
Multiple Sclerosis Journal. 2017; 23(S3):591-592.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
FullText
** Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M
The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS.
[Poster]
Web of Science
FullText
** Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M
Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science
FullText
** Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M
No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM.
[Poster]
Web of Science
** Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M
Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY.
[Poster]
Web of Science